Low Versus High-glycemic Index Post-exercise Diets for Improving Metabolism and Body Composition

June 10, 2020 updated by: Phil Chilibeck, University of Saskatchewan

Endurance Training and Post-exercise Low Glycemic Index Recovery Diet for Improving Postprandial Triglycerides

Postprandial triglycerides are a strong risk factor for heart disease. The purpose is to assess the effects of a low-glycemic versus high-glycemic meal after 90 minute exercise sessions that are done 4 times a week for 6 weeks on postprandial triglyceride level. Secondary measurements include other lipids and body composition.

Study Overview

Detailed Description

The increase in triglycerides after a meal (i.e. postprandial triglycerides) is a strong risk factor for cardiovascular disease. Overweight/obese individuals have a greater triglyceride response to the same meal compared to lean individuals; therefore they are at greater risk. If exercise is performed the evening before a high-fat breakfast, the postprandial levels of triglycerides after the breakfast are reduced; however, if high glycemic index (GI) foods are consumed after the exercise session, the benefits of exercise on next-day postprandial triglycerides is negated. The investigators recently showed (HSFC funded) that consuming low GI foods after exercise is similar to fasting after exercise and superior to consumption of high GI foods for lowering next-day postprandial triglycerides. Low GI food was also superior for increasing fat oxidation, and lowering insulin, and low and very low density lipoproteins and preventing a decrease in high density lipoproteins. The benefits of an acute exercise session followed by low GI food consumption is now clear; however, it is not known whether this practice over weeks of exercise training results in accumulated and sustained benefits.

The purpose of this study is to determine the chronic effects of consuming low compared to high GI foods after exercise sessions over six weeks in overweight and obese individuals.

Twenty-four overweight and obese males and females will be randomized to consume either high or low GI foods immediately after exercise sessions (four sessions per week, 90 minutes per session, six weeks). At all other times of the day over the six weeks, they will be supplied a moderate GI diet, with calories and macronutrients based on four-day food diaries completed before the study. Two weeks before the intervention, participants will be required to go on the moderate GI diet, as a lead-in. One week into the lead-in, a baseline test will be done to determine postprandial metabolic responses (i.e. triglycerides, low and very low density lipoproteins, high density lipoproteins, insulin, and fat oxidation) after a morning high-fat breakfast. A week later, the same postprandial testing will be carried out the morning after the first exercise and post-exercise consumption of a low or high GI recovery meal. Participants will continue the training and post-exercise food consumption for the next six weeks, with postprandial measures taken again following the final exercise and feeding session. Body composition and aerobic fitness will be determined before and after the six week intervention.

The investigators hypothesize that the low GI post-exercise feeding will be superior to the high GI post-exercise feeding for reducing body fat, improving fat oxidation, and reducing postprandial triglycerides, insulin and other harmful lipids. The results of the study will provide clinicians, exercise professionals and dietitians unique and experimentally tested strategies for their clients to lose body fat and improve metabolic profiles, to reduce the risk of heart disease.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Saskatchewan
      • Saskatoon, Saskatchewan, Canada, S7N 5B2
        • University of Saskatchewan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 44 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Overweight or obese (BMI 25 or greater)

Exclusion Criteria:

  • Smokers
  • Diabetic
  • Taking medications that affect carbohydrate or lipid metabolism

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Low glycemic index post-exercise diet
Lentil-based post-exercise meal
Feeding of a low-glycemic index, lentil meal after 90 minutes of walking exercise
ACTIVE_COMPARATOR: High glycemic index post-exercise diet
Instant potato, white bread, and egg white post-exercise meal
Feeding of a high-glycemic index meal (i.e. instant mashed potatoes, white bread, egg whites) after 90 minutes of walking exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial triglycerides
Time Frame: Change from baseline to 1 week and 6 weeks
Triglyceride from serum
Change from baseline to 1 week and 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial cholesterol
Time Frame: Change from baseline to 1 week and 6 weeks
Cholesterol from serum
Change from baseline to 1 week and 6 weeks
Postprandial low density lipoprotein
Time Frame: Change from baseline to 1 week and 6 weeks
Low density lipoprotein from serum
Change from baseline to 1 week and 6 weeks
Postprandial high density lipoprotein
Time Frame: Change from baseline to 1 week and 6 weeks
High density lipoprotein from serum
Change from baseline to 1 week and 6 weeks
Postprandial glucose
Time Frame: Change from baseline to 1 week and 6 weeks
Glucose from serum
Change from baseline to 1 week and 6 weeks
Postprandial insulin
Time Frame: Change from baseline to 1 week and 6 weeks
Insulin from serum
Change from baseline to 1 week and 6 weeks
Fasting Triglyceride
Time Frame: Change from baseline to 1 week and 6 weeks
Triglyceride from serum
Change from baseline to 1 week and 6 weeks
Fasting cholesterol
Time Frame: Change from baseline to 1 week and 6 weeks
Cholesterol from serum
Change from baseline to 1 week and 6 weeks
Fasting LDL-cholesterol
Time Frame: Change from baseline to 1 week and 6 weeks
LDL from serum
Change from baseline to 1 week and 6 weeks
Fasting HDL-cholesterol
Time Frame: Change from baseline to 1 week and 6 weeks
HDL from serum
Change from baseline to 1 week and 6 weeks
Fasting glucose
Time Frame: Change from baseline to 1 week and 6 weeks
Glucose from serum
Change from baseline to 1 week and 6 weeks
Fasting Insulin
Time Frame: Change from baseline to 1 week and 6 weeks
Insulin from serum
Change from baseline to 1 week and 6 weeks
Postprandial fat oxidation
Time Frame: Change from baseline to 1 week and 6 weeks
Fat oxidation assessed by expiratory gases
Change from baseline to 1 week and 6 weeks
Fat mass
Time Frame: Change from baseline to 6 weeks
Fat mass assessed by dual energy x-ray absorptiometry
Change from baseline to 6 weeks
Waist Girth
Time Frame: Change from baseline to 6 weeks
Waist girth assessed by a measurement tape
Change from baseline to 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 15, 2018

Primary Completion (ACTUAL)

September 30, 2019

Study Completion (ACTUAL)

December 30, 2019

Study Registration Dates

First Submitted

June 27, 2018

First Submitted That Met QC Criteria

July 12, 2018

First Posted (ACTUAL)

July 16, 2018

Study Record Updates

Last Update Posted (ACTUAL)

June 11, 2020

Last Update Submitted That Met QC Criteria

June 10, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 17-171

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypercholesterolemia

Clinical Trials on Low glycemic index post-exercise diet

3
Subscribe